Cargando…

Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS

Background: Determination of psychotropic drugs in clinical study is significant, and the establishment of methodologies for these drugs in biological matrices is essential for patients’ safety. The search for new methods for their detection is one of the most important challenges of modern scientif...

Descripción completa

Detalles Bibliográficos
Autores principales: Petruczynik, Anna, Wróblewski, Karol, Wojtanowski, Krzysztof, Mroczek, Tomasz, Juchnowicz, Dariusz, Karakuła-Juchnowicz, Hanna, Tuzimski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321162/
https://www.ncbi.nlm.nih.gov/pubmed/32471141
http://dx.doi.org/10.3390/molecules25112483
_version_ 1783551401490644992
author Petruczynik, Anna
Wróblewski, Karol
Wojtanowski, Krzysztof
Mroczek, Tomasz
Juchnowicz, Dariusz
Karakuła-Juchnowicz, Hanna
Tuzimski, Tomasz
author_facet Petruczynik, Anna
Wróblewski, Karol
Wojtanowski, Krzysztof
Mroczek, Tomasz
Juchnowicz, Dariusz
Karakuła-Juchnowicz, Hanna
Tuzimski, Tomasz
author_sort Petruczynik, Anna
collection PubMed
description Background: Determination of psychotropic drugs in clinical study is significant, and the establishment of methodologies for these drugs in biological matrices is essential for patients’ safety. The search for new methods for their detection is one of the most important challenges of modern scientific research. The methods for analyzing of psychotropic drugs and their metabolites in different biological samples should be based on combining a very efficient separation technique including high-performance liquid chromatography (HPLC), with a sensitive detection method and effectively sample preparation methods. Objective: Retention, peaks symmetry and system efficiency of vortioxetine on Hydro RP, Polar RP, HILIC A (with silica stationary phase), HILIC-B (with aminopropyl stationary phase), and ACE HILIC-N (with polyhydroxy stationary phase and SCX columns were investigated. Various mobile phases containing methanol or acetonitrile as organic modifiers and different additives were also applied to obtained optimal retention, peaks shape, and systems efficiency. The best chromatographic procedure was used for simultaneous analysis of vortioxetine and its metabolites in human serum, urine and saliva samples. Methods: Analysis of vortioxetine was performed in various chromatographic systems: Reversed phase (RP) systems on alkylbonded or phenyl stationary phases, hydrophilic interaction liquid chromatography (HILIC), and ion-exchange chromatography (IEC). Based on the dependence of log k vs the concentration of the organic modifier, log kw values for vortioxetine in various chromatographic systems were determined and compared with calculated log P values. Solid phase extraction (SPE) method was applied for sample pre-treatment before HPLC analysis. HPLC-QTOF-MS method was applied for confirmation of presence of vortioxetine and some its metabolites in biological samples collected from psychiatric patient. Conclusions: Differences were observed in retention parameters with a change of the applied chromatographic system. The various properties of stationary phases resulted in differences in vortioxetine retention, systems’ efficiency, and peaks’ shape. Lipophilicity parameters were also determined using different HPLC conditions. The most optimal systems were chosen for the analysis of vortioxetine in biological samples. Both serum and urine or saliva samples collected from patients treated with vortioxetine can be used for the drug determination. For the first time, vortioxetine was detected in patient’s saliva. Obtained results indicate on possibility of application of saliva samples, which collection are non-invasive and painless, for determination and therapeutic drug monitoring in patients.
format Online
Article
Text
id pubmed-7321162
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73211622020-07-06 Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS Petruczynik, Anna Wróblewski, Karol Wojtanowski, Krzysztof Mroczek, Tomasz Juchnowicz, Dariusz Karakuła-Juchnowicz, Hanna Tuzimski, Tomasz Molecules Article Background: Determination of psychotropic drugs in clinical study is significant, and the establishment of methodologies for these drugs in biological matrices is essential for patients’ safety. The search for new methods for their detection is one of the most important challenges of modern scientific research. The methods for analyzing of psychotropic drugs and their metabolites in different biological samples should be based on combining a very efficient separation technique including high-performance liquid chromatography (HPLC), with a sensitive detection method and effectively sample preparation methods. Objective: Retention, peaks symmetry and system efficiency of vortioxetine on Hydro RP, Polar RP, HILIC A (with silica stationary phase), HILIC-B (with aminopropyl stationary phase), and ACE HILIC-N (with polyhydroxy stationary phase and SCX columns were investigated. Various mobile phases containing methanol or acetonitrile as organic modifiers and different additives were also applied to obtained optimal retention, peaks shape, and systems efficiency. The best chromatographic procedure was used for simultaneous analysis of vortioxetine and its metabolites in human serum, urine and saliva samples. Methods: Analysis of vortioxetine was performed in various chromatographic systems: Reversed phase (RP) systems on alkylbonded or phenyl stationary phases, hydrophilic interaction liquid chromatography (HILIC), and ion-exchange chromatography (IEC). Based on the dependence of log k vs the concentration of the organic modifier, log kw values for vortioxetine in various chromatographic systems were determined and compared with calculated log P values. Solid phase extraction (SPE) method was applied for sample pre-treatment before HPLC analysis. HPLC-QTOF-MS method was applied for confirmation of presence of vortioxetine and some its metabolites in biological samples collected from psychiatric patient. Conclusions: Differences were observed in retention parameters with a change of the applied chromatographic system. The various properties of stationary phases resulted in differences in vortioxetine retention, systems’ efficiency, and peaks’ shape. Lipophilicity parameters were also determined using different HPLC conditions. The most optimal systems were chosen for the analysis of vortioxetine in biological samples. Both serum and urine or saliva samples collected from patients treated with vortioxetine can be used for the drug determination. For the first time, vortioxetine was detected in patient’s saliva. Obtained results indicate on possibility of application of saliva samples, which collection are non-invasive and painless, for determination and therapeutic drug monitoring in patients. MDPI 2020-05-27 /pmc/articles/PMC7321162/ /pubmed/32471141 http://dx.doi.org/10.3390/molecules25112483 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Petruczynik, Anna
Wróblewski, Karol
Wojtanowski, Krzysztof
Mroczek, Tomasz
Juchnowicz, Dariusz
Karakuła-Juchnowicz, Hanna
Tuzimski, Tomasz
Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title_full Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title_fullStr Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title_full_unstemmed Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title_short Comparison of Various Chromatographic Systems for Identification of Vortioxetine in Bulk Drug Substance, Human Serum, Saliva, and Urine Samples by HPLC-DAD and LC-QTOF-MS
title_sort comparison of various chromatographic systems for identification of vortioxetine in bulk drug substance, human serum, saliva, and urine samples by hplc-dad and lc-qtof-ms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321162/
https://www.ncbi.nlm.nih.gov/pubmed/32471141
http://dx.doi.org/10.3390/molecules25112483
work_keys_str_mv AT petruczynikanna comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT wroblewskikarol comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT wojtanowskikrzysztof comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT mroczektomasz comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT juchnowiczdariusz comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT karakułajuchnowiczhanna comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms
AT tuzimskitomasz comparisonofvariouschromatographicsystemsforidentificationofvortioxetineinbulkdrugsubstancehumanserumsalivaandurinesamplesbyhplcdadandlcqtofms